Free Trial

Ainos (AIMDW) Competitors

$0.18 +0.05 (+38.46%)
As of 01/22/2025 03:59 PM Eastern

AIMDW vs. ATNFW, LBPSW, AEHAW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Ainos stock or one of its competitors? The main competitors of Ainos include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Ainos vs.

Ainos (NASDAQ:AIMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Ainos and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
AinosN/AN/A
180 Life SciencesN/AN/A

In the previous week, Ainos had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Ainos and 0 mentions for 180 Life Sciences. Ainos' average media sentiment score of 0.50 beat 180 Life Sciences' score of 0.00 indicating that Ainos is being referred to more favorably in the media.

Company Overall Sentiment
Ainos Positive
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$40.63KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Ainos beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Ainos News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIMDW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIMDW vs. The Competition

MetricAinosMedical Devices IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.34B$5.45B$9.16B
Dividend YieldN/A2.37%5.36%3.97%
P/E RatioN/A217.9156.3613.19
Price / SalesN/A203.931,313.9479.68
Price / CashN/A15.3844.6537.72
Price / BookN/A4.375.004.72
Net IncomeN/A$77.46M$117.81M$224.61M
7 Day Performance5.88%0.76%2.07%1.41%
1 Month PerformanceN/A10.49%3.46%4.13%
1 Year PerformanceN/A24.68%25.40%21.37%

Ainos Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AIMDW
Ainos
N/A$0.18
+38.5%
N/A+50.0%$0.00$40,633.000.0040
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+81.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
flat
N/A-81.9%$0.00N/A0.002
ALVOW
Alvotech
N/A$3.16
-1.3%
N/A-7.3%$0.00$391.87M0.004Gap Up
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
flat
N/A+36.3%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.08
flat
N/AN/A$0.00$35.36M0.0070
BTMDW
biote
N/A$0.51
flat
N/AN/A$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.15
flat
N/A-93.1%$0.00N/A0.008
CELUW
Celularity
N/A$0.03
flat
N/A+39.3%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:AIMDW) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners